We have placed cookies on your computer to help make this website better. We use a PIWIK Analytics script which sets performance cookies. More details and information can be found in our cookie policy. Please refer to the privacy statement to adjust your settings for the website analytics tracking by PIWIK (e.g. deny use/opt-out). More info.


Dr. Philip Just Larsen

Member of the Corporate Executive Board, Chief Scientific Officer

Dr. Philip Just Larsen, Chief Scientific Officer (CSO) Grünenthal

“At Grünenthal, our research efforts are all about offering patients pain relief and thereby increasing their quality of life in a way that’s almost impossible to describe using words or figures. We couldn’t wish for a more meaningful reason for our daily work and keep pushing for innovative therapies every day.”

Dr. Philip Just Larsen

Chief Scientific Officer

Philip Just Larsen is an entrepreneurial researcher who has experienced the pharmaceutical industry from many different angles. An MD trained in internal medicine and neurology, he founded and led the biopharmaceutical company Rheoscience A/S, and held senior management roles in various stock market listed companies, including the role of Chief Scientific Officer at Sanofi’s German Hub in Frankfurt. Philip joined Grünenthal as Chief Scientific Officer and Member of the Corporate Executive Board in July 2018.

He is convinced that “with our scientific curiosity, the specific expertise in pain, in-house capabilities for all stages of drug development, and the shared motivation to serve patients in need, Grünenthal has everything that is needed to take pain management to the next level.”

Dr. Philip Just Larsen at a glance

Nationality: Danish

Year of birth: 1962

Education: Ph.D. in Neuroscience/Endocrinology, University of Copenhagen

Family status: Married, two children

Career highlights

Since 07/2018: Chief Scientific Officer and Member of the Corporate Executive Board, Grünenthal

01/2016 – 06/2018: Chief Scientific Officer German Hub, Sanofi

08/2012 – 06/2018: : Global Head of Diabetes Research and Translational Science, Sanofi

10/2008 – 04/2011: : CSO Diabetes Research, Lilly